IN BRIEF: Haleon says Pfizer representative steps down from board

Related news

Haleon PLC - Weybridge, Surrey-based consumer healthcare firm that spun out of GSK PLC in 2022 - Says Pfizer Inc representative Bryan Supran stepped down as a non-executive director on the Haleon board on Tuesday, following the reduction of Pfizer’s stake in Haleon to less than 10%, and in line with the two firms’ prior relationship agreement.

Haleon Chair Dave Lewis says: ‘On behalf of the board, I would like to thank Bryan for his contributions to the board’s discussions and for being part of the Haleon journey from the initial joint-venture in 2019 through demerger to today. We wish him all the very best for the future.’

Current stock price: 396.50 pence, down 0.1% in London on Tuesday afternoon

12-month change: up 22%

Copyright 2025 Alliance News Ltd. All Rights Reserved.

Directors

Ways to help you invest your money

Our investment accounts

Put your money to work with our range of investment accounts. Choose from ISAs, pensions, and more.

Need some investment ideas?

Let us give you a hand choosing investments. From managed funds to favourite picks, we’re here to help.

Read our expert tips and insights

Our investment experts share their knowledge on how to keep your money working hard across the markets.